Type: Upload file
Artist impression of designed mini-protein binders targeting Influenza hemagglutinin to effectively bind and neutralize the virus.
(Downloadable video soundbites and lab b-roll) Scientist David Baker discusses creating proteins custom tailored to specific therapeutic targets. See related story.
Alzheimer’s is a slow-progressing disease that can be latent for 15 years before developing into cognitive impairment and dementia. And evidence suggests that healthy behaviors can delay the...
Jesse Fann, professor of psychiatry and behavioral sciences at the University of Washington School of Medicine, is the lead author of a paper in Lancet Psychiatry, "Long-term risk of dementia among...
Mother's Day can be a struggle if your mother or loved one has memory loss or dementia. Karen Clay, a social worker with the UW Medicine Memory and Brain Wellness Center in Seattle, offers tips for...
Retired Supreme Court Justice Sandra Day O’Connor announced Tuesday that she has been diagnosed with “the beginning stages of dementia, probably Alzheimer’s.” Currently no cure exists for the slow-...
It's best for patients to express concerns about memory problems to their doctor early on, before symptoms become worse. Their doctor can either rule out a medical problem or put into motion...
Dr. Cecilia Lee, assistant professor of opthalmology with the University of Washington School of Medicine, is lead author of a study published Aug. 8 in Alzheimer's & Dementia: The Journal of the...
The Institute for Protein Design will become an innovation hub for new therapeutics for a variety of common, serious diseases. It will also engineer new nanomaterials for industry. Through computer...